Xenon Pharmaceuticals Q3 EPS $(0.33) Beats $(0.48) Estimate, Sales $3.5M

Xenon Pharmaceuticals (NASDAQ:XENE) reported quarterly losses of $(0.33) per share which beat the analyst consensus estimate of $(0.48) by 31.25 percent. This is a 47.62 percent increase over losses of $(0.63) per share

Benzinga · 11/05/2019 21:24

Xenon Pharmaceuticals (NASDAQ:XENE) reported quarterly losses of $(0.33) per share which beat the analyst consensus estimate of $(0.48) by 31.25 percent. This is a 47.62 percent increase over losses of $(0.63) per share from the same period last year. The company reported $3.5 million in sales this quarter.